AMEX · REED

Reed's, Inc.

$0.92 -$0.01 (-1.51%) 1D Market open

Key Metrics

$11.03M
Market cap
P/E · TTM
$31.18M
Revenue · TTM
−$20.28M
Net income
EPS · TTM $-2.68
Dividend yield
Free cash flow −$17.79M
Beta · 1Y -0.26
EBITDA · TTM −$19.47M
Gross margin 13.7%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Mar 23 high, the share price fell 82%.

    Peak close $4.96 on Mar 23; trough close $0.92 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -82%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 13
    The stock moved -28.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 13
  • Mar 27
    The stock moved +28.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 27

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$11.03M
Enterprise value
Shares outstanding11.9M
52-wk range$0.80 – $7.00
Avg volume · 20D39.2K
Net cash
Book value / share$0.36
IndustryBottled & Canned Soft Drinks & Carbonated Waters
ExchangeAMEX
About Reed's, Inc.
IPO dateDec 29, 2006
Employees44

Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.35
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 13.7%
Operating -62.9%
Net -65.0%
FCF -57.1%
ROE / ROIC -434.2% · —

Financial Health

Current ratio1.11
Quick ratio0.58
Debt / equity
Debt / EBITDA
Net cash
Working capital$1.65M

Cash Flow · TTM

Operating CF −$17.52M
Capex −$272.00K
Free cash flow −$17.79M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-14.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings